Paul D Rubin insider trades

Open-market stock purchases and sales by Paul D Rubin, Chief Medical Officer at BioAge Labs, Inc, from SEC Form 4 filings since May 31, 2011.

Recent trades

DateStockTradeValue
Apr 1, 2026BIOA BioAge Labs, IncSold$157K
Apr 1, 2026BIOA BioAge Labs, IncBought (not open market)—
Apr 1, 2026BIOA BioAge Labs, IncBought (not open market)—
Mar 2, 2026BIOA BioAge Labs, IncSold$151K
Mar 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Mar 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Feb 17, 2026BIOA BioAge Labs, IncBought (not open market)—
Feb 2, 2026BIOA BioAge Labs, IncSold$139K
Feb 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Feb 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Jan 2, 2026BIOA BioAge Labs, IncSold$95.5K
Jan 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Jan 2, 2026BIOA BioAge Labs, IncBought (not open market)—
Dec 9, 2025BIOA BioAge Labs, IncSold$216K
Dec 9, 2025BIOA BioAge Labs, IncBought (not open market)—
Dec 4, 2025BIOA BioAge Labs, IncSold$702K
Dec 4, 2025BIOA BioAge Labs, IncBought (not open market)—

Companies traded

  • BIOA BioAge Labs, Inc: 6 sales, last Apr 1, 2026
  • MGEN Miragen Therapeutics, Inc: other filings, last Jan 31, 2018
  • XOMA XOMA Corp: 39 sales, last Mar 22, 2016

Get free alerts when Paul D Rubin files a new trade →